Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
PUT
Progressive
PGR
$127B
| $3.56M | ﹤0.01% |
+16,300
| New | +$3.29M |
|
1477
Avient
AVNT
$4.1B
| $3.54M | ﹤0.01% |
95,908
-48,709
| -34% | -$1.76M |
|
1478
CALL
General Dynamics
GD
$104B
| $3.54M | ﹤0.01% |
+10,000
| New | +$3.43M |
|
|
ECG
1479
Everus Construction Group
ECG
$6.43B
| $3.54M | ﹤0.01% |
21,336
+11,078
| +108% | +$1.62M |
|
1480
PUT
Hims & Hers Health
HIMS
$7.88B
| $3.54M | ﹤0.01% |
102,100
+80,900
| +382% | +$2.17M |
|
1481
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.93B
| $3.54M | ﹤0.01% |
+22,938
| New | +$3.84M |
|
1482
PUT
Teradyne
TER
$58.7B
| $3.53M | ﹤0.01% |
7,300
+4,700
| +181% | +$1.77M |
|
1483
PUT
CAVA Group
CAVA
$8.6B
| $3.53M | ﹤0.01% |
45,000
-4,200
| -9% | -$352K |
|
1484
J&J Snack Foods
JJSF
$1.64B
| $3.53M | ﹤0.01% |
47,994
-71,507
| -60% | -$5.57M |
|
1485
Hallador Energy
HNRG
$725M
| $3.51M | ﹤0.01% |
202,042
+140,565
| +229% | +$2.42M |
|
1486
PUT
Thermo Fisher Scientific
TMO
$233B
| $3.51M | ﹤0.01% |
7,000
+3,200
| +84% | +$1.54M |
|
1487
PUT
Zscaler
ZS
$29.4B
| $3.5M | ﹤0.01% |
+24,800
| New | +$3.46M |
|
1488
CALL
Nike
NKE
$60.5B
| $3.5M | ﹤0.01% |
85,200
+38,100
| +81% | +$1.68M |
|
1489
PUT
Cboe Global Markets
CBOE
$31.4B
| $3.49M | ﹤0.01% |
+14,400
| New | +$4.41M |
|
1490
PUT
Cadence Design Systems
CDNS
$87.9B
| $3.49M | ﹤0.01% |
9,300
-600
| -6% | -$210K |
|
1491
PUT
Valero Energy
VLO
$100B
| $3.49M | ﹤0.01% |
13,400
-4,600
| -26% | -$1.13M |
|
1492
Nuveen Credit Strategies Income Fund
JQC
$702M
| $3.48M | ﹤0.01% |
716,157
-99,369
| -12% | -$479K |
|
1493
Crane NXT
CXT
$2.89B
| $3.48M | ﹤0.01% |
67,996
-136,003
| -67% | -$5.8M |
|
|
MRSH
1494
Marsh
MRSH
$91.6B
| $3.47M | ﹤0.01% |
20,849
+8,361
| +67% | +$1.4M |
|
1495
CALL
Bath & Body Works
BBWI
$3.92B
| $3.47M | ﹤0.01% |
150,000
-75,000
| -33% | -$1.43M |
|
1496
PUT
Nu Holdings
NU
$70.4B
| $3.46M | ﹤0.01% |
258,700
| – | – |
|
1497
PUT
Western Digital
WDC
$166B
| $3.45M | ﹤0.01% |
5,400
-4,300
| -44% | -$2.09M |
|
|
KLRA
1498
Kailera Therapeutics
KLRA
$2.23B
| $3.41M | ﹤0.01% |
+154,838
| New | +$3.4M |
|
1499
Reynolds Consumer Products
REYN
$5.37B
| $3.4M | ﹤0.01% |
126,704
-428,814
| -77% | -$9.55M |
|
|
NIQ
1500
NIQ Global Intelligence PLC
NIQ
$5.54B
| $3.4M | ﹤0.01% |
+363,797
| New | +$3.52M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.